Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FCBP
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -60.26 0.27 0.69
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -48.20 -7.74 -5.22
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.18 24.75 23.98
Cash 25.55 29.86 23.78
Capex 77.85 < 0.005 < 0.005
Free Cash Flow -97.48 0.08 3.21
Revenue -5.37 2.24 2.36
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin inf 0.00 1.00
Operating Margin 36267.30 0.54 < 0.005
ROA 60.71 0.09 0.06
ROE -11.70 0.03 0.04
ROIC -19101.70 -0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FCBP is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FCBP is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FCBP is permitted for members.